Upgrade to SI Premium - Free Trial

DTCFF (DTCFF)

0.29 +0.04 (16.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Defence Therapeutics Wins Best Poster Award and Takes Center Stage at World ADC San Diego 2026, a Key Recognition in the Field Highlighting the Potential of Its Accum Platform October 19, 2026 3:16 AM - StreetInsider Defence Therapeutics to Take the Stage at World ADC San Diego to Discuss the Next Frontier in Antibody-Drug Conjugates October 1, 2026 3:17 AM - StreetInsider Defence Therapeutics names ex-Xenon CFO Sherry Aulin to its board September 29, 2026 3:16 AM - StreetInsider Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors September 29, 2026 3:16 AM - StreetInsider Defence Therapeutics Provides Corporate Update as Company Executes on Strategic Priorities September 28, 2026 5:02 PM - StreetInsider Defence Therapeutics CEO outlines three strategic priorities in letter September 8, 2026 6:13 AM - StreetInsider Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders September 8, 2026 3:17 AM - StreetInsider Defence Therapeutics Provides Updates on Sharing Agreement September 4, 2026 6:02 PM - StreetInsider Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs August 31, 2026 3:17 AM - StreetInsider Defence Therapeutics names Ryan Simms as COO and radiopharmaceutical head August 17, 2026 3:17 AM - StreetInsider Defence Therapeutics Strengthens Radiopharmaceutical Leadership with Appointment of Dr. Ryan Simms as Chief Operating Officer and Head of Radiopharmaceutical Programs August 17, 2026 3:17 AM - StreetInsider Defence Therapeutics names Dr. Amie Phinney as CEO August 4, 2026 3:17 AM - StreetInsider Defence Therapeutics Appoints Dr. Amie Phinney as President and Chief Executive Officer August 4, 2026 3:17 AM - StreetInsider Full Article List